The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.

NCT05337969 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

To Determine Bioequivalence Under Fed Conditions

Interventions

DRUG: Metformin and Vildagliptin 850/50 mg

Sponsor

AET Laboratories Private Limited